These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18769464)

  • 1. Insights into PPARgamma from structures with endogenous and covalently bound ligands.
    Nettles KW
    Nat Struct Mol Biol; 2008 Sep; 15(9):893-5. PubMed ID: 18769464
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
    Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
    J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomic structure of mutant PPARgamma LBD complexed with 15d-PGJ2: novel modulation mechanism of PPARgamma/RXRalpha function by covalently bound ligands.
    Waku T; Shiraki T; Oyama T; Morikawa K
    FEBS Lett; 2009 Jan; 583(2):320-4. PubMed ID: 19101554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial agonists activate PPARgamma using a helix 12 independent mechanism.
    Bruning JB; Chalmers MJ; Prasad S; Busby SA; Kamenecka TM; He Y; Nettles KW; Griffin PR
    Structure; 2007 Oct; 15(10):1258-71. PubMed ID: 17937915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation mechanism of PPARgamma by its endogenous ligands].
    Shiraki T; Kamiya N; Jingami H
    Tanpakushitsu Kakusan Koso; 2005 Nov; 50(13):1660-5. PubMed ID: 16277244
    [No Abstract]   [Full Text] [Related]  

  • 6. Protein polarization is critical to stabilizing AF-2 and helix-2' domains in ligand binding to PPAR-gamma.
    Ji CG; Zhang JZ
    J Am Chem Soc; 2008 Dec; 130(50):17129-33. PubMed ID: 19007119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel PPARalpha ligands by the structural modification of a PPARgamma ligand.
    Usui S; Fujieda H; Suzuki T; Yoshida N; Nakagawa H; Miyata N
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3249-54. PubMed ID: 16621530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the activation of PPARgamma by oxidized fatty acids.
    Itoh T; Fairall L; Amin K; Inaba Y; Szanto A; Balint BL; Nagy L; Yamamoto K; Schwabe JW
    Nat Struct Mol Biol; 2008 Sep; 15(9):924-31. PubMed ID: 19172745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARgamma by FABP4.
    Ayers SD; Nedrow KL; Gillilan RE; Noy N
    Biochemistry; 2007 Jun; 46(23):6744-52. PubMed ID: 17516629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2D QSAR of PPARgamma agonist binding and transactivation.
    Rücker C; Scarsi M; Meringer M
    Bioorg Med Chem; 2006 Aug; 14(15):5178-95. PubMed ID: 16650995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirement for PPARgamma binding revealed by a meta analysis of holo-crystal structures.
    Nascimento AS
    Biochimie; 2010 May; 92(5):499-506. PubMed ID: 20138109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular recognition of nitrated fatty acids by PPAR gamma.
    Li Y; Zhang J; Schopfer FJ; Martynowski D; Garcia-Barrio MT; Kovach A; Suino-Powell K; Baker PR; Freeman BA; Chen YE; Xu HE
    Nat Struct Mol Biol; 2008 Aug; 15(8):865-7. PubMed ID: 18604218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand entry pathways in the ligand binding domain of PPARγ receptor.
    Aci-Sèche S; Genest M; Garnier N
    FEBS Lett; 2011 Aug; 585(16):2599-603. PubMed ID: 21782815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSAIDs revisited: putative molecular basis of their interactions with peroxisome proliferator-activated gamma receptor (PPARgamma).
    Romeiro NC; Sant'Anna CM; Lima LM; Fraga CA; Barreiro EJ
    Eur J Med Chem; 2008 Sep; 43(9):1918-25. PubMed ID: 18222570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of covalent bond formation between PPARγ and oxo-fatty acids.
    Egawa D; Itoh T; Yamamoto K
    Bioconjug Chem; 2015 Apr; 26(4):690-8. PubMed ID: 25785518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ.
    Shang J; Brust R; Mosure SA; Bass J; Munoz-Tello P; Lin H; Hughes TS; Tang M; Ge Q; Kamenekca TM; Kojetin DJ
    Elife; 2018 Dec; 7():. PubMed ID: 30575522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening of potentially endocrine-disrupting chemicals against nuclear receptors and its application to identify PPARγ-bound fatty acids.
    Jaladanki CK; He Y; Zhao LN; Maurer-Stroh S; Loo LH; Song H; Fan H
    Arch Toxicol; 2021 Jan; 95(1):355-374. PubMed ID: 32909075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternate binding site for PPARγ ligands.
    Hughes TS; Giri PK; de Vera IM; Marciano DP; Kuruvilla DS; Shin Y; Blayo AL; Kamenecka TM; Burris TP; Griffin PR; Kojetin DJ
    Nat Commun; 2014 Apr; 5():3571. PubMed ID: 24705063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The many faces of PPARgamma: anti-inflammatory by any means?
    Szanto A; Nagy L
    Immunobiology; 2008; 213(9-10):789-803. PubMed ID: 18926294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of full-length PPARgamma-RXRalpha: a snapshot of a functional complex?
    Moras D
    Cell Metab; 2009 Jan; 9(1):8-10. PubMed ID: 19117542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.